Granulocyte Colony-Stimulating Factor (GCSF) Use with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone plus /- Rituximab ( CHOP±R) Treatment for Aggressive Non-Hodgkin's Lymphoma (aNHL)

被引：0
|
作者：
Kouroukis, Tom [1 ]
Cheung, Winson Y. [2 ]
Abdel-Samad, Nizar [3 ]
Sehdev, Sandeep [4 ]
Poulin-Costello, Melanie [5 ]
Gillesby, Brad [5 ]
Robson, Ewan J. D. [5 ]
机构：
[1] Juravinski Canc Ctr, Hamilton, ON, Canada
[2] British Columbia Canc Agcy, Vancouver, BC, Canada
[3] Moncton Hosp, Moncton, NB, Canada
[4] William Osler Hlth Syst, Brampton, ON, Canada
[5] Amgen Canada Inc, Mississauga, ON, Canada
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3038.3038
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3038
引用
收藏
页数：6
相关论文
共 50 条
  • [1] CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma
    Alliot, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4797 - 4799
  • [2] CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma
    Doorduijn, JK
    van der Holt, B
    van Imhoff, GW
    van der Hem, KG
    Kramer, MHH
    van Oers, MHJ
    Ossenkoppele, GJ
    Schaafsma, MR
    Verdonck, LF
    Verhoef, GEG
    Steijaert, MMC
    Buijt, I
    Uyl-de Groot, CA
    van Agthoven, M
    Mulder, AH
    Sonneveld, P
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3041 - 3050
  • [3] CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma - Reply
    Doorduijn, JK
    Sonneveld, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4799 - 4800
  • [4] Front-line immunochemotherapy for aggressive non-Hodgkin lymphoma using dose-dense rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone plus granulocyte-macrophage colony stimulating factor and pegfilgrastim as support
    Cabanillas, Fernando
    Cotto, Maribel
    Liboy, Idalia
    Rivera, Ezequiel
    Pavia, Orestes A.
    Bruno, Margarita
    LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 1929 - 1933
  • [5] Results of treatment with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) for non-Hodgkin's aggressive lymphoma analyzed according to the International Prognostic Index
    Aydin, F
    Ulusoy, S
    Ovali, E
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (06) : 446 - 451
  • [6] CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study
    Niitsu, N
    Okamoto, M
    Kuraishi, Y
    Nakamura, S
    Kodama, F
    Hirano, M
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (03) : 188 - 194
  • [7] High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study
    P Pronzato
    R Lionetto
    F Botto
    F Pensa
    A Tognoni
    British Journal of Cancer, 1998, 78 : 777 - 780
  • [8] High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study
    Pronzato, P
    Lionetto, R
    Botto, F
    Pensa, F
    Tognoni, A
    BRITISH JOURNAL OF CANCER, 1998, 78 (06) : 777 - 780
  • [9] Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjogren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas
    Voulgarelis, M
    Giannouli, S
    Anagnostou, D
    Tzioufas, AG
    RHEUMATOLOGY, 2004, 43 (08) : 1050 - 1053
  • [10] Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin’s lymphoma
    R. I. Fisher
    Cancer Chemotherapy and Pharmacology, 1997, 40 : S42 - S46
12345